Completed
A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors
NCT00046111
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, Small Cell, +9 more
- Locations
-
- GSK Investigational Site New York, United States
- GSK Investigational Site Philadelphia, Pennsylvania, United States
- GSK Investigational Site Nashville, Tennessee, United States
- GSK Investigational Site San Antonio, Texas, United States